Second-quarter revenue grew 26%, including May 24 acquisition of Evoqua; up 15% organically Second-quarter earnings per share of $0.45 , down 27%; adjusted earnings per share of $0.98 , up 32% Raising full-year revenue guidance to approximately $7.2B , up 30%, with organic revenue growth of 9% to
